Capital Analysts LLC’s Verastem VSTM Stock Holding History

Capital Analysts LLC’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-83	Closed	-$1K	–	813
2020 Q3	$1K	Hold	83	–	–	﹤0.01%	746
2020 Q2	$2K	Hold	83	–	–	﹤0.01%	671
2020 Q1	$3K	Buy	+83	New	+$2.08K	﹤0.01%	627

Other funds holding VSTM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ACM

Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Capital Analysts LLC's VSTM Position: Q4 2020 in Review

Capital Analysts LLC sold out of Verastem (VSTM) in Q4 2020, closing a stake of 83 shares — an estimated $1K sold.

Capital Analysts LLC first reported a position in VSTM in Q1 2020 and held it in 3 quarters. The position peaked at $3K in Q1 2020. 130 funds tracked by Wall St. Rank hold VSTM as of Q4 2020.

Capital Analysts LLC reported no remaining Verastem position as of Q4 2020 after selling out during the quarter.
Capital Analysts LLC sold 83 Verastem shares in Q4 2020, an estimated $1K.
Capital Analysts LLC first reported a position in Verastem in Q1 2020 and held it in 3 quarters.
Capital Analysts LLC's Verastem position peaked at $3K in Q1 2020.
130 funds tracked by Wall St. Rank held Verastem as of Q4 2020.

Based on Capital Analysts LLC's 13F filing for Q4 2020, filed 16 Feb 2021.